Stock FAQs

pfizer stock price history

by Kelvin Feil Published 2 years ago Updated 2 years ago
image

Is Pfizer a good stock?

So, is PFE stock a good investment right now? PFE stock isn’t a buy right now, according to technical analysis. The company, on the other hand, is likely to record positive growth in the fourth ...

Should I buy Pfizer?

Pfizer currently has a Zacks Rank #2 (Buy).You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. Another stock with the same Zacks Rank is GlaxoSmithKline GSK. Glaxo’s stock has risen 27.2% in the past year. Estimates for Glaxo’s 2022 earnings have gone up from $3.25 to $3.29 over the past 60 days.

What is wrong with Pfizer stock price?

Pfizer Inc.’s ability to supply billions of doses of its Covid-19 vaccine hinges on two employees working on opposite sides of the world. From her home in Andover, Mass., Amy Genest scouts for companies that can make Pfizer’s shot. After finding a ...

Is Pfizer Inc. (PFE) a good stock to buy?

Pfizer Inc. expects to bring in more than $50 billion in revenue this year from its COVID-19 vaccine and oral medication, further cementing the company’s role as the world’s go-to pharmaceutical partner in the pandemic.

image

What is the highest price Pfizer stock has been?

The latest closing stock price for Pfizer as of July 06, 2022 is 52.75.The all-time high Pfizer stock closing price was 61.25 on December 16, 2021.The Pfizer 52-week high stock price is 61.71, which is 17% above the current share price.More items...

What was Pfizer stock price in 1999?

PFE - Pfizer Inc.DateOpenClose*Oct 01, 199933.8037.65Sep 01, 199936.2334.04Aug 04, 19990.075901 DividendAug 01, 199931.9035.8281 more rows

Is Pfizer Buy Sell or Hold?

A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80)....Momentum Scorecard. More Info.Zacks RankDefinitionAnnualized Return1Strong Buy24.75%2Buy18.15%3Hold9.70%4Sell5.35%2 more rows

What years did Pfizer stock split?

Pfizer has split its stock a total of five times: July 1, 1983: a 2-for-1 split. April 1, 1991: a 2-for-1 split. July 3, 1995: a 2-for-1 split.

How much did Pfizer stock go up after Viagra?

Positive news about Viagra's sales drove Pfizer's stock price to a record $113.75 in trading on the New York Stock Exchange yesterday, though by the close the stock had fallen a bit, to $113.37 1/2. That was a jump of nearly 8 percent from Friday's close.

What price did Pfizer stock split?

For example, a 2000 share position pre-split, became a 4000 share position following the split. PFE's third split took place on July 03, 1995....PFE Split History TableDateRatio07/01/19993 for 111/17/20201054 for 10004 more rows

Is Pfizer a blue chip stock?

Some blue chips, such as Apple and Pfizer, take the hit and keep on chugging.

What is the target price for Pfizer?

Stock Price TargetsHigh$75.00Median$55.00Low$49.00Average$57.46Current Price$51.75

Is Pfizer going to split?

Pfizer announced on 29 July that it will split off its Upjohn off-patent branded and generics business and merge it with Mylan NV to establish a top generic drug company, with $19bn to $20bn in pro forma 2020 revenues.

How often Pfizer pays dividends?

4 dividends per yearThere are typically 4 dividends per year (excluding specials), and the dividend cover is approximately 2.0. Our premium tools have predicted Pfizer Inc.

Is Pfizer a dividend aristocrat?

The Pfizer dividend has been paid since 1980 and has increased the dividend for 12 consecutive years; qualifying the company as a Dividend Contender. PFE used to be a Dividend Aristocrat until it cut its dividend during the great recession.

Who owns Pfizer stock?

The top shareholders of Pfizer are Frank A. D'amelio, John Douglas Young, Mikael Dolsten, Vanguard Group Inc., BlackRock Inc. (BLK), and State Street Corp. (STT).

4 Companies That Can Benefit From Buying Back More Stock

COVID-19 shot interval can be extended to 8 weeks for some -U.S. CDC

Pfizer, Nike, Walmart, and Broadcom are among the companies that have built up a war chest of cash and are considered prime buyback candidates.

Sanofi-Glaxo Vaccine May Threaten Pfizer, Moderna in Covid-19 Booster Market

Extending the interval between the first two doses of the most widely used COVID-19 vaccines in the country to eight weeks for young men can reduce the rare risk of heart inflammation, U.S. health officials said.

image
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 1 2 3 4 5 6 7 8 9